Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
4
×
deals
san francisco
san francisco blog main
san francisco top stories
lung cancer
new york blog main
startups
10x genomics
astellas pharma
auris health
auris surgical robots
becton dickinson
boehringer ingelheim
cancer
cancer diagnostics
clinical trials
d1 capital partners
diagnostic device
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
frederic moll
genetic testing
idiopathic pulmonary fibrosis (ipf)
indiana blog main
indiana top stories
intuitive surgical
investing
invitae
lux capital
lymphoma
medical device
merck
mithril capital
What
expand
4
×
deal
help
medical
tests
ability
acquire
adding
aims
approval
array
auris
babies
bid
bio
boehringer
business
clearance
company
cost
decisions
diabetes
diagnostic
diagnostics
drug
eli
fallen
fda
fold
funding
genetic
health
ingelheim
invitae
lands
lilly
low
lung
make
maker
Language
unset
Current search:
expand
×
biotech
×
" national blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot